Although increased serum TNF-α levels during the first three days after the onset of disease symptoms are associated with disease severity, there are no significant differences in serum TNF-α levels among COVID-19 patients with mild, severe, and critical symptoms. This evidence concerns the gene TNF and COVID-19.